MazenNabilNasrallahMD

Rheumatology • Boston, MA

Physician

Join to view full profile

Dr. Nasrallah is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Nasrallah's full profile

Already have an account?

Office
55 Fruit St
Boston, MA 02114
Phone+1 617-726-2000

Fax+1 617-726-4803
Is this information wrong?

Education & Training

Massachusetts General HospitalFellowship, Rheumatology, 2016 - 2019
Cleveland Clinic FoundationResidency, Internal Medicine, 2013 - 2016
University of Jordan Faculty of MedicineClass of 2010

Certifications & Licensure

MA State Medical License 2016 - 2024
ME State Medical License 2021 - 2022
OH State Medical License 2013 - 2016
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Publications & Presentations

PubMed

Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor.
Steven M Blum, Daniel A Zlotoff, Neal P Smith, Isabela J Kernin, Swetha Ramesh, Leyre Zubiri, Joshua Caplin, Nandini Samanta, Sidney C Martin, Alice Tirard, Pritha Sen...> ;Biorxiv. 2023 Nov 29
6 citations
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer.
Leyre Zubiri, Gabriel E. Molina, Meghan J. Mooradian, Justine V. Cohen, Sienna Durbin, Laura A. Petrillo, Genevieve M. Boland, Dejan Juric, Michael Dougan, Molly Thoma...> ;Journal for Immunotherapy of Cancer. 2021 Sep 1
16 citations
Predictors of rheumatic immune-related adverse events and de novo inflammatory arthritis after immune checkpoint inhibitor treatment for cancer
Amy Cunningham-Bussel, Jiaqi Wang, Lauren C. Prisco, Lily W Martin, Kathleen M M Vanni, Alessandra Zaccardelli, Mazen Nasrallah, Lydia Gedmintas, Lindsey A MacFarlane,...> ;Arthritis & Rheumatology. 2021 Aug 16
19 citations
Temporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018
Gabriel E. Molina, Leyre Zubiri, Justine V. Cohen, Sienna Durbin, Laura A. Petrillo, Ian M. Allen, Yonina R. Murciano-Goroff, Michael Dougan, Molly Thomas, Alexander T...> ;The Oncologist. 2021 Jun 1
5 citations
Using electronic visits (E-visits) to achieve goal serum urate levels in patients with gout in a rheumatology practice: A pilot study.
Chio Yokose, April Jorge, Kristin M. D’Silva, Naomi Serling-Boyd, Mark Matza, Mazen Nasrallah, Sarah F. Keller, Amar Oza, Hyon K. Choi, Marcy B. Bolster, Deborah S. Co...> ;Seminars in Arthritis and Rheumatism. 2020 Mar 16
47 citations
Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience.
Meghan J. Mooradian, Mazen Nasrallah, Justin F. Gainor, Kerry L. Reynolds, Justine V. Cohen, Donald P. Lawrence, Eli M. Miloslavsky, Minna J. Kohler, Ryan J. Sullivan,...> ;Seminars in Arthritis and Rheumatism. 2019 Jun 1
128 citations
Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy.
Mauro Di Pilato, Edward Y. Kim, Bruno L. Cadilha, Jasper N. Prüßmann, Mazen Nasrallah, Davide Seruggia, Shariq M. Usmani, Sandra Misale, Valentina Zappulli, Esteban Ca...> ;Nature. 2019 May 15
23 citations
Reanalysis of the Rituximab in ANCA- Associated Vasculitis trial identifies granulocyte subsets as a novel early marker of successful treatment
Mazen Nasrallah, Yannick Pouliot, Bjoern Hartmann, Patrick Dunn, Elizabeth Thomson, Jeffrey Wiser, Atul J. Butte> ;Arthritis Research & Therapy. 2015 Sep 21
Join now to see all